Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

NCT00293475 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma

Interventions

DRUG: Carboplatin
DRUG: Mannitol
DRUG: Methotrexate
OTHER: Quality-of-Life Assessment
BIOLOGICAL: Rituximab
DRUG: Sodium Thiosulfate

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]